Home

Rand Brüllen Gehört eliquis vs xarelto gi bleeding ungesund Ergebnis Faulheit

Overall Rates of GI Bleeding by Treatment Arm | Download Table
Overall Rates of GI Bleeding by Treatment Arm | Download Table

Restarting Warfarin vs Direct Oral Anticoagulants After Major  Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A  Cohort Study - Clinical Gastroenterology and Hepatology
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study - Clinical Gastroenterology and Hepatology

Evaluation of bleeding in patients receiving direct oral anticoagulant |  VHRM
Evaluation of bleeding in patients receiving direct oral anticoagulant | VHRM

Management of anticoagulation in patients with acute gastrointestinal  bleeding - ScienceDirect
Management of anticoagulation in patients with acute gastrointestinal bleeding - ScienceDirect

Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral  Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect

Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral  Anticoagulants in Atrial Fibrillation: A Systematic Review and  Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology

GI bleeding up for new users of rivaroxaban
GI bleeding up for new users of rivaroxaban

History of bleeding and outcomes with apixaban versus warfarin in patients  with atrial fibrillation in the Apixaban for Reduction in Stroke and Other  Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect

New predictive model for acute gastrointestinal bleeding in patients taking  oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology  and Hepatology - Wiley Online Library
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... |  Download Scientific Diagram
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram

Eliquis vs Xarelto: Which Is Better in Afib? | MedPage Today
Eliquis vs Xarelto: Which Is Better in Afib? | MedPage Today

Non-major bleeding with apixaban versus warfarin in patients with atrial  fibrillation | Heart
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart

No INRs! RNs Role Caring for Patients on Oral Anticoagulant Therapy - ppt  download
No INRs! RNs Role Caring for Patients on Oral Anticoagulant Therapy - ppt download

Comparison of NOACs in risk of major bleeding in patients with AF. AF =...  | Download Scientific Diagram
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian  patients with non-valvular atrial fibrillation: An updated meta-analysis
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis

ESC 2015 Meeting Report
ESC 2015 Meeting Report

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in  Asian Patients with Atrial Fibrillation | Scientific Reports
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large  Population-Based Study - Gastroenterology
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study - Gastroenterology

GI bleeding on anticoagulants
GI bleeding on anticoagulants

Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban,  or edoxaban (treatment) versus warfarin (control) (observational) - Stroke  Prevention in Patients With Atrial Fibrillation: A Systematic Review Update  - NCBI Bookshelf
Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus warfarin (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf

Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban,  or edoxaban (treatment) versus dabigatran (control) (observational) -  Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review  Update - NCBI Bookshelf
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf

What gastroenterologists should know about direct oral anticoagulants -  Digestive and Liver Disease
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With  Atrial Fibrillation Unsuitable for Warfarin | Stroke
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke

GI bleeding more common with rivaroxaban than other direct oral  anticoagulants
GI bleeding more common with rivaroxaban than other direct oral anticoagulants